https://m.cjdby.net/forum.php?mod=viewthread&tid=2869585&extra=page%3D1&mobile=2
China’s Sinovac Shot Found Highly Effective in Real World Study
中国科兴疫苗在现实环境中非常有效
May 11, 2021, 5:00 PM EDT
Sinovac Biotech Ltd.’s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical trials.
在印尼科兴疫苗消灭了医护人员中的新冠案例
Indonesia tracked 25,374 health workers in capital city Jakarta for 28 days after they received their second dose and found that the vaccine protected 100% of them from death and 96% from hospitalization as soon as seven days after, said Health Minister Budi Gunadi Sadikin in an interview on Tuesday. The workers were tracked until late February.
印尼的卫生部长在一个访谈中说印尼跟踪了25,374个打了两剂科兴疫苗在雅加达工作的医务人员28天后的反应。发现疫苗对死亡有效率是百分百,对住院保护率在打完第二针七天后就有96%。
Sadikin also said that 94% of the workers had been protected against infection -- an extraordinary result that goes beyond what was measured in the shot’s numerous clinical trials -- though it’s unclear if the workers were uniformly screened to detect asymptomatic carriers.
卫生部长还说疫苗对感染的保护率是94%
“We see a very, very drastic drop,” in hospitalizations and deaths among medical workers, Sadikin said. It’s not known what strain of the coronavirus Sinovac’s shot worked against in Indonesia, but the country has not flagged any major outbreaks driven by variants of concern.
卫生部长说医护人员的住院率直线下降。
The data adds to signs out of Brazil that the Sinovac shot is more effective than it proved in the testing phase, which was beset by divergent efficacy rates and questions over data transparency. Results from its biggest Phase III trial in Brazil put the shot known as CoronaVac’s efficacy at just above 50%, the lowest among all first-generation Covid vaccines.
印尼的数据验证了巴西的数据,证明科兴疫苗在现实环境中的有效率比三期的好很多
https://udn.com/news/story/120944/5451071?from=udn-ch1_breaknews-1-0-news
一項在印尼醫務人員中進行的研究顯示,中國製的「科興疫苗」(Sinovac Biotech Ltd.)能提供有效保護,這對數十個依賴該疫苗的開發中國家來說是一個令人鼓舞的信號,因為此前的臨床試驗中,該疫苗的效果遠遜於西方疫苗。
印尼衛生部長薩迪金(Budi Gunadi Sadikin)11日接受專訪時表示,該國首都雅加達25374名醫務人員在接種第二劑疫苗後接受了28天的追蹤,發現該疫苗在完成接種的7天後就能100%保護接種者免於死亡,還能讓96%的人免於住院。對這些接種者的追蹤持續到2月下旬。
獄中人生
關閉廣告